US6607884B1
(en)
|
1993-03-19 |
2003-08-19 |
The Johns Hopkins University School Of Medicine |
Methods of detecting growth differentiation factor-8
|
EP1333035A3
(de)
|
1993-03-19 |
2004-07-07 |
The Johns Hopkins University School Of Medicine |
Wachstumsdifferenzierungsfaktor-8
|
US7393682B1
(en)
|
1993-03-19 |
2008-07-01 |
The Johns Hopkins University School Of Medicine |
Polynucleotides encoding promyostatin polypeptides
|
US6465239B1
(en)
|
1993-03-19 |
2002-10-15 |
The John Hopkins University School Of Medicine |
Growth differentiation factor-8 nucleic acid and polypeptides from aquatic species and non-human transgenic aquatic species
|
US7566768B1
(en)
|
1995-10-26 |
2009-07-28 |
The Johns Hopkins University School Of Medicine |
Promyostatin peptides and methods of using same
|
ES2213745T3
(es)
|
1993-05-12 |
2004-09-01 |
Genetics Institute, Llc |
Composiciones de bmp-11.
|
US7332575B2
(en)
|
1994-03-18 |
2008-02-19 |
The Johns Hopkins University School Of Medicine |
Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species
|
US20030167492A1
(en)
|
1994-07-08 |
2003-09-04 |
Johns Hopkins University School Of Medicine |
Transgenic non-human animals expressing a gdf-11 dominant negative polypeptide, and methods of making and using same
|
US6008434A
(en)
|
1994-07-08 |
1999-12-28 |
Johns Hopkins University School Of Medicine |
Growth differentiation factor-11 transgenic mice
|
US5846770A
(en)
*
|
1994-11-22 |
1998-12-08 |
Genetics Institute, Inc. |
DNA molecules encoding human chordin
|
US6524802B1
(en)
*
|
1996-03-29 |
2003-02-25 |
The Johns Hopkins University School Of Medicine |
Methods of detecting growth differentiation factor-14
|
US5965403A
(en)
|
1996-09-18 |
1999-10-12 |
Genetics Institute, Inc. |
Nucleic acids encoding bone morphogenic protein-16 (BMP-16)
|
US7041641B2
(en)
|
1997-03-20 |
2006-05-09 |
Stryker Corporation |
Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
|
US20010016646A1
(en)
|
1998-03-20 |
2001-08-23 |
David C. Rueger |
Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
|
EP2309261A1
(de)
|
1997-05-30 |
2011-04-13 |
Stryker Corporation |
Verfahren zur Beurteilung von Gewebemorphogenese und- aktivität
|
US6696260B1
(en)
*
|
1997-08-01 |
2004-02-24 |
The Johns Hopkins University School Of Medicine |
Methods to identify growth differentiation factor (GDF) binding proteins
|
US6891082B2
(en)
*
|
1997-08-01 |
2005-05-10 |
The Johns Hopkins University School Of Medicine |
Transgenic non-human animals expressing a truncated activintype II receptor
|
US20020052026A1
(en)
|
1997-10-08 |
2002-05-02 |
Steven M. Vicik |
Methods of refolding proteins
|
WO1999024057A2
(en)
*
|
1997-11-07 |
1999-05-20 |
Genetics Inst |
Neuronal uses of bmp-11
|
US6027917A
(en)
*
|
1997-12-10 |
2000-02-22 |
Genetics Institute, Inc. |
Bone morphogenetic protein (BMP)-17 and BMP-18 compositions
|
CA2319703C
(en)
*
|
1998-02-05 |
2005-09-20 |
The Johns Hopkins University School Of Medicine |
Growth differentiation factor-8
|
US6369201B1
(en)
*
|
1998-02-19 |
2002-04-09 |
Metamorphix International, Inc. |
Myostatin multimers
|
US7147839B2
(en)
|
1998-05-29 |
2006-12-12 |
Curis, Inc. |
Methods for evaluating tissue morphogenesis and activity
|
NZ509609A
(en)
*
|
1998-07-28 |
2003-11-28 |
Univ Johns Hopkins Med |
Disrupting growth differentiation factor-11 (GDF-11) to increase the muscle and bone tissue in animals
|
WO2000043781A2
(en)
*
|
1999-01-21 |
2000-07-27 |
Metamorphix, Inc. |
Growth differentiation factor inhibitors and uses therefor
|
US6727224B1
(en)
|
1999-02-01 |
2004-04-27 |
Genetics Institute, Llc. |
Methods and compositions for healing and repair of articular cartilage
|
US6555374B1
(en)
*
|
1999-08-19 |
2003-04-29 |
Artecel Sciences, Inc. |
Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof
|
TWI329129B
(en)
|
2001-02-08 |
2010-08-21 |
Wyeth Corp |
Modified and stabilized gdf propeptides and uses thereof
|
KR100420798B1
(ko)
*
|
2001-02-10 |
2004-03-02 |
(주)알에이싸이언스 |
펩타이드 벡터
|
TWI267378B
(en)
|
2001-06-08 |
2006-12-01 |
Wyeth Corp |
Calcium phosphate delivery vehicles for osteoinductive proteins
|
US7320789B2
(en)
*
|
2001-09-26 |
2008-01-22 |
Wyeth |
Antibody inhibitors of GDF-8 and uses thereof
|
US6798160B2
(en)
*
|
2001-11-02 |
2004-09-28 |
Honda Giken Kogyo Kabushiki Kaisha |
Electric working machine
|
GB2385052A
(en)
*
|
2002-02-05 |
2003-08-13 |
Leuven K U Res & Dev |
Treatment of spondyloarthropathies
|
WO2003072714A2
(en)
*
|
2002-02-21 |
2003-09-04 |
Wyeth |
Follistatin domain containing proteins
|
KR20040094709A
(ko)
|
2002-02-21 |
2004-11-10 |
와이어쓰 |
폴리스타틴 도메인을 포함하는 단백질
|
US7527966B2
(en)
|
2002-06-26 |
2009-05-05 |
Transgenrx, Inc. |
Gene regulation in transgenic animals using a transposon-based vector
|
US20040172667A1
(en)
|
2002-06-26 |
2004-09-02 |
Cooper Richard K. |
Administration of transposon-based vectors to reproductive organs
|
EP2192129A1
(de)
*
|
2002-09-16 |
2010-06-02 |
Johns Hopkins University |
Metalloproteaseaktivierung von Myostatin sowie Verfahren zur Modulation der Myostatinaktivität
|
US7261893B2
(en)
|
2002-10-22 |
2007-08-28 |
Wyeth |
Neutralizing antibodies against GDF-8 and uses therefor
|
US20040223966A1
(en)
*
|
2002-10-25 |
2004-11-11 |
Wolfman Neil M. |
ActRIIB fusion polypeptides and uses therefor
|
CA2526669A1
(en)
*
|
2003-06-02 |
2004-12-16 |
Wyeth |
Use of myostatin (gdf8) inhibitors in conjunction with corticosteroids for treating neuromuscular disorders
|
ATE357244T1
(de)
|
2003-09-12 |
2007-04-15 |
Wyeth Corp |
Injizierbare feste calciumphosphat-stäbe zur abgabe von osteogenen proteinen
|
US8071364B2
(en)
*
|
2003-12-24 |
2011-12-06 |
Transgenrx, Inc. |
Gene therapy using transposon-based vectors
|
ES2350939T3
(es)
|
2004-03-10 |
2011-01-28 |
Scil Technology Gmbh |
Implantes recubiertos, su fabricación y uso de los mismos.
|
WO2005116052A2
(en)
|
2004-04-27 |
2005-12-08 |
Research Development Foundation |
ANTAGONISM OF TGF-β SUPERFAMILY RECEPTOR SIGNALING
|
WO2005115438A1
(en)
|
2004-05-25 |
2005-12-08 |
Stryker Corporation |
Use of morphogenic proteins for treating cartilage defects
|
EP1778275A2
(de)
*
|
2004-08-12 |
2007-05-02 |
Wyeth |
Kombinationstherapie für diabetes, adipositas und herz-kreislauf-erkrankungen unter verwendung von gdf-8-hemmern
|
US7473678B2
(en)
|
2004-10-14 |
2009-01-06 |
Biomimetic Therapeutics, Inc. |
Platelet-derived growth factor compositions and methods of use thereof
|
AU2006226878A1
(en)
*
|
2005-03-23 |
2006-09-28 |
Wyeth |
Detection of GDF-8 modulating agents
|
AU2006232914A1
(en)
*
|
2005-03-23 |
2006-10-12 |
Wyeth |
Detection of an immune response to GDF-8 modulating agents
|
CA2624976A1
(en)
|
2005-10-06 |
2007-04-19 |
Eli Lilly And Company |
Anti-myostatin antibodies
|
UA92504C2
(en)
*
|
2005-10-12 |
2010-11-10 |
Эли Лилли Энд Компани |
Anti-myostatin monoclonal antibody
|
US8147860B2
(en)
|
2005-12-06 |
2012-04-03 |
Etex Corporation |
Porous calcium phosphate bone material
|
EP2311505B1
(de)
|
2006-02-09 |
2013-11-06 |
BioMimetic Therapeutics, LLC |
Zusammensetzungen und Verfahren zur Behandlung von Knochen
|
JP5219359B2
(ja)
|
2006-02-21 |
2013-06-26 |
日東電工株式会社 |
反射性及び/又は遮光性を有する粘着テープ又はシート、および液晶表示装置
|
WO2007142818A2
(en)
|
2006-05-17 |
2007-12-13 |
Stryker Corporation |
Use of a soluble morphogenic protein complex for treating cartilage defects
|
AU2007269712B2
(en)
|
2006-06-30 |
2013-02-07 |
Biomimetic Therapeutics, Llc |
PDGF-biomatrix compositions and methods for treating rotator cuff injuries
|
US9161967B2
(en)
|
2006-06-30 |
2015-10-20 |
Biomimetic Therapeutics, Llc |
Compositions and methods for treating the vertebral column
|
US8524265B2
(en)
|
2006-08-17 |
2013-09-03 |
Warsaw Orthopedic, Inc. |
Medical implant sheets useful for tissue regeneration
|
PT2066695E
(pt)
|
2006-09-05 |
2013-05-23 |
Lilly Co Eli |
Anticorpos anti-miostatina
|
AU2007234612B2
(en)
|
2006-12-14 |
2013-06-27 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein stabilization formulations
|
EP2120859B1
(de)
|
2006-12-21 |
2013-11-20 |
Stryker Corporation |
Formulierungen mit verzögerter freisetzung mit kristallen von bmp-7
|
US7678764B2
(en)
|
2007-06-29 |
2010-03-16 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein formulations for use at elevated temperatures
|
WO2009020744A1
(en)
|
2007-08-07 |
2009-02-12 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein formulations comprising gdf-5 in aqueous acidic solution
|
PE20091163A1
(es)
*
|
2007-11-01 |
2009-08-09 |
Wyeth Corp |
Anticuerpos para gdf8
|
WO2009102966A2
(en)
|
2008-02-13 |
2009-08-20 |
Keith Hruska |
Method of treating vascular sclerosis
|
WO2009129101A1
(en)
|
2008-04-14 |
2009-10-22 |
Advanced Technologies And Regenerative Medicine, Llc |
Liquid buffered gdf-5 formulations
|
US8216997B2
(en)
|
2008-08-14 |
2012-07-10 |
Acceleron Pharma, Inc. |
Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
|
EP2341951A2
(de)
|
2008-09-09 |
2011-07-13 |
BioMimetic Therapeutics, Inc. |
Aus thrombozyten stammende wachstumsfaktor-zusammensetzungen und verfahren zur behandlung von sehnen- und bänderverletzungen
|
US9150880B2
(en)
|
2008-09-25 |
2015-10-06 |
Proteovec Holding, L.L.C. |
Vectors for production of antibodies
|
US9157097B2
(en)
|
2008-09-25 |
2015-10-13 |
Proteovec Holding, L.L.C. |
Vectors for production of growth hormone
|
CA2752157A1
(en)
|
2009-02-12 |
2010-08-19 |
Stryker Corporation |
Peripheral administration of proteins including tgf-.beta. superfamily members for systemic treatment of disorders and disease
|
CN102369017A
(zh)
|
2009-02-12 |
2012-03-07 |
史赛克公司 |
用于微创系统性递送包含TGF-β超家族成员的蛋白质的组合物和方法
|
WO2010110974A1
(en)
|
2009-03-24 |
2010-09-30 |
Stryker Corporation |
Methods and compositions for tissue engineering
|
US8609127B2
(en)
|
2009-04-03 |
2013-12-17 |
Warsaw Orthopedic, Inc. |
Medical implant with bioactive material and method of making the medical implant
|
WO2010118360A1
(en)
|
2009-04-09 |
2010-10-14 |
The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Production of proteins using transposon-based vectors
|
KR20120049214A
(ko)
*
|
2009-06-08 |
2012-05-16 |
악셀레론 파마 인코포레이티드 |
발열성 지방세포를 증가시키는 방법
|
US20110002897A1
(en)
|
2009-06-11 |
2011-01-06 |
Burnham Institute For Medical Research |
Directed differentiation of stem cells
|
EP3805259A1
(de)
|
2009-06-12 |
2021-04-14 |
Acceleron Pharma Inc. |
Verkürzte actriib-fc-fusionsproteine
|
WO2011031856A1
(en)
|
2009-09-09 |
2011-03-17 |
Stryker Corporation |
Bmp -7 for use in treating pain induced by injuries and diseases of an articular joint
|
CA2774024A1
(en)
|
2009-09-17 |
2011-03-24 |
Stryker Corporation |
Buffers for controlling the ph of bone morphogenetic proteins
|
JP2013514811A
(ja)
|
2009-12-22 |
2013-05-02 |
ストライカー コーポレイション |
免疫原性が抑制されたbmp−7変異体
|
CN102811622A
(zh)
|
2010-02-22 |
2012-12-05 |
生物模拟治疗公司 |
用于治疗腱病的血小板衍生生长因子组合物和方法
|
WO2014012101A1
(en)
|
2012-07-13 |
2014-01-16 |
Trustees Of Tufts College |
Silk powder compaction for production of constructs with high mechanical strength and stiffness
|
CN113604550A
(zh)
*
|
2012-10-24 |
2021-11-05 |
细胞基因公司 |
用于治疗贫血症的生物标志物
|
CA2889286A1
(en)
*
|
2012-10-24 |
2014-05-01 |
Celgene Corporation |
Methods for treating anemia
|
CN104936605A
(zh)
|
2012-11-02 |
2015-09-23 |
细胞基因公司 |
激活素-actrii拮抗剂和用于治疗骨和其它病症的用途
|
US20160120945A1
(en)
*
|
2013-02-15 |
2016-05-05 |
The Brigham And Women's Hospital, Inc. |
Thymic Regeneration
|
EP4140497A1
(de)
|
2013-04-08 |
2023-03-01 |
President and Fellows of Harvard College |
Zusammensetzungen zum verjüngen von stammzellen der skelettmuskulatur
|
US20160287667A1
(en)
*
|
2013-11-08 |
2016-10-06 |
President And Fellows Of Harvard College |
Methods and compositions for rejuvenating neuromuscular junctions
|
AU2014407088B2
(en)
|
2014-09-26 |
2021-09-23 |
Somalogic Operating Co., Inc. |
Cardiovascular risk event prediction and uses thereof
|
US10307480B2
(en)
|
2014-11-06 |
2019-06-04 |
Scholar Rock, Inc. |
Anti-pro/latent-myostatin antibodies and uses thereof
|
WO2017015622A2
(en)
*
|
2015-07-22 |
2017-01-26 |
Scholar Rock, Inc |
Gdf11 binding proteins and uses thereof
|
PT3350220T
(pt)
|
2015-09-15 |
2021-08-06 |
Scholar Rock Inc |
Anticorpos anti-pró-miostatina/miostatina latente e suas utilizações
|
JP7025021B2
(ja)
|
2015-10-26 |
2022-02-24 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
還元多糖および酸化多糖ならびにそれらの使用の方法
|
CN109310742B
(zh)
|
2016-01-06 |
2022-12-02 |
哈佛学院校长同事会 |
使用gdf11的治疗防止体重增加、提高葡萄糖耐量并减轻脂肪肝
|
SG11201805709RA
(en)
|
2016-01-08 |
2018-07-30 |
Scholar Rock Inc |
Anti-pro/latent myostatin antibodies and methods of use thereof
|
KR20230169484A
(ko)
|
2016-06-13 |
2023-12-15 |
스칼러 락, 인크. |
미오스타틴 억제제의 용도 및 조합 요법
|
US11155611B2
(en)
|
2017-01-06 |
2021-10-26 |
Scholar Rock, Inc. |
Compositions and methods for making and using anti-myostatin antibodies
|